Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens
- Resource Type
- Review Article
- Source
- In
The Lancet Infectious Diseases July 2019 19(7):e246-e252 - Subject
Review and Opinion Personal View - Language
- ISSN
- 1473-3099